PUBLICATIONS · 38899716
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2024 Nov 7
- First author
- Long GV
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Long GV
- type
- Author
- name
- Hauschild A
- type
- Author
- name
- Santinami M
- type
- Author
- name
- Kirkwood JM
- type
- Author
- name
- Atkinson V
- type
- Author
- name
- Mandala M
- type
- Author
- name
- Merelli B
- type
- Author
- name
- Sileni VC
- type
- Author
- name
- Nyakas M
- type
- Author
- name
- Haydon A
- type
- Author
- name
- Dutriaux C
- type
- Author
- name
- Robert C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Long GV
- type
- Author
- name
- Hauschild A
- type
- Author
- name
- Santinami M
- type
- Author
- name
- Kirkwood JM
- type
- Author
- name
- Atkinson V
- type
- Author
- name
- Mandala M
- type
- Author
- name
- Merelli B
- type
- Author
- name
- Sileni VC
- type
- Author
- name
- Nyakas M
- type
- Author
- name
- Haydon A
- type
- Author
- name
- Dutriaux C
- type
- Author
- name
- Robert C
- type
- Author
- bibliography ids
- nci-bib-2af310b6aba87aeec8bd5ec2
- book metadata
- content sha256
- 44af3bc4da68ffd24965b296cbf5086ec1ec1f840a169fe92ace29ea26e5ab4e
- document type
- citation
- dois
- 10.1056/NEJMoa2404139
- electronic publication date
- display
- 2024 Jun 19
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38899716
- immutable id
- pubmed:38899716@44af3bc4da68ffd24965b296cbf5086ec1ec1f840a169fe92ace29ea26e5ab4e
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 18
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 1709-1720
- volume
- 391
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 38899716
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- 0b2b6718901bb2beb8860866f444fa7dbdb9a3530b26379f95e706c20dafc044
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2024 Nov 7
- precision
- day
- year
- 2024
- publication types
- Journal Article
- Randomized Controlled Trial
- Multicenter Study
- Clinical Trial, Phase III
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Preserved source evidence · Not medical advice
Triangle